Skip to main content

Table 1 Failed neonatal hearing screening: multivariate logistic regression of risk factors

From: Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants

 

Failed neonatal hearing screening [% (n failed hearing screening/n with risk factor)

OR

95% CI

p

All

11% (788/7056)

Ref.

  

Birth weight#

 

0.91

0.88-0.94

7.3 × 10-10*

No Aminoglycosides, m.1555A>G -

8.5% (224/2636)

1.26

1.07-1.49

0.0058*

No Aminoglycosides m.1555A>G +

0% (0/2)

Aminoglycosides m.1555A>G -

12.7% (561/4408)

Aminoglycosides m.1555A>G +

30% (3/10)

Vancomycin treatment

15.8% (349/2208)

1.24

1.04-1.47

0.015

Furosemide treatment

17.6% (238/1355)

1.29

1.08-1.57

0.0066*

Cytomegalovirus-infection

27% (6/22)

1.80

0.69-4.7

0.23

Infants with BPD

18.6% (195/1048)

1.21

0.99-1.49

0.067

  1. #OR for birth weight is given per 100 g increased weight. Percentage of failed hearing screening for each category is given in Figure 1. *p < 0.007, multivariate logistic regression.